US2008146530A1PendingUtilityA1

Re-epithelializing pharmaceutical compositions comprising xanthan gum

51
Assignee: SIFI SPAPriority: Apr 30, 2002Filed: Feb 14, 2008Published: Jun 19, 2008
Est. expiryApr 30, 2022(expired)· nominal 20-yr term from priority
A61P 43/00A61P 25/04A61P 29/00A61P 27/02A61P 31/00A61K 31/573A61K 9/06A61K 31/7036A61K 47/36A61K 31/715A61K 31/661A61K 31/723A61K 9/0048A61P 17/00A61P 17/02A61K 31/728
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of xanthan gum as re-epithelializing agent and, in particular, to a pharmaceutical formulation comprising xanthan gum as a re-epithelializing active principle eventually mixed with hyaluronic acid. Said use and composition speed up and improve advantageously the formation of newly grown epithelium.

Claims

exact text as granted — not AI-modified
1 - 19 . (canceled) 
     
     
         20 . Pharmaceutical composition consisting of: 
       
         
           
                 
                 
                 
               
                     
                 
                   Dexamethasone disodium phosphate 
                   0.1500 g 
                   Active principle 
                 
                   Netilmicin sulfate 
                   0.4550 g 
                   Active principle 
                 
                   equivalent to 
                 
                   Netilmicin base 
                   0.3000 g 
                 
                   Xanthan gum 
                   1.0000 g 
                   Active principle, 
                 
                     
                     
                   re-epithelializing 
                 
                   Sodium phosphate dibasic•12H 2 O 
                   0.5000 g 
                   Buffer 
                 
                   Sodium phosphate monobasic•H 2 O 
                   0.1465 g 
                   Buffer 
                 
                   Sodium citrate•2H 2 O 
                   2.1000 g 
                   Antioxidant 
                 
                   Purified water q.s. to 
                    100.0 ml 
                   Solvent 
                 
                     
                 
             
                
               
               
                
                
                
                
                
                
                
                
                
                
                
               
            
           
         
       
     
     
         21 - 23 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.